Tusk Therapeutics to Present Data at AACR Annual Meeting 2018

London and Stevenage, UK – 28 March 2018: Tusk Therapeutics, an immuno-oncology company focused on developing immune-modulating therapeutics by targeting immune cells in cancer, announces today that it will deliver an oral presentation and three poster presentations at the 2018 American Association for Cancer Research (AACR) Annual Meeting taking place from 14th – 18th April 2018 at McCormick Place North/South, … Read More